X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (324) 324
Newspaper Article (22) 22
Patent (16) 16
Book Review (5) 5
Book / eBook (3) 3
Conference Proceeding (1) 1
Dissertation (1) 1
Library Holding (1) 1
Publication (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (98) 98
female (58) 58
gastroenterology & hepatology (55) 55
male (52) 52
adult (43) 43
liver (38) 38
middle aged (38) 38
liver transplantation (33) 33
transplantation (32) 32
cirrhosis (25) 25
liver diseases (24) 24
mortality (22) 22
risk factors (21) 21
management (19) 19
randomized controlled trials as topic (19) 19
surgery (19) 19
treatment outcome (19) 19
aged (18) 18
medicine, general & internal (18) 18
cholangitis (17) 17
medicine general & introductory medical sciences (16) 16
risk (16) 16
survival (16) 16
disease (15) 15
patients (15) 15
analysis (14) 14
fibrosis (14) 14
time factors (14) 14
transplants & implants (14) 14
treatment (14) 14
diagnosis (13) 13
disease progression (13) 13
gastroenterology and hepatology (13) 13
network meta-analysis (13) 13
physics (13) 13
prognosis (13) 13
quality of life (13) 13
abridged index medicus (12) 12
cancer (12) 12
liver disorders (12) 12
primary sclerosing cholangitis (12) 12
young adult (12) 12
animals (11) 11
athletes (11) 11
medical interventions (11) 11
methods (11) 11
retrospective studies (11) 11
natural-history (10) 10
network meta‐analysis (10) 10
pregnancy (10) 10
hepatology (9) 9
hospitals (9) 9
risk assessment (9) 9
risk-factors (9) 9
therapy (9) 9
adolescent (8) 8
allografts (8) 8
autoimmune liver disease (8) 8
cell biology (8) 8
endoscopy (8) 8
fatty liver (8) 8
hepatitis c (8) 8
odds ratio (8) 8
pharmacology & pharmacy (8) 8
primary biliary-cirrhosis (8) 8
severity of illness index (8) 8
syngeneic grafts (8) 8
adverse effects (7) 7
biopsy (7) 7
cholangiocarcinoma (7) 7
clinical trials (7) 7
cohort studies (7) 7
complications (7) 7
drug therapy (7) 7
education (7) 7
electric communication technique (7) 7
electricity (7) 7
gastroenterology (7) 7
hypertension (7) 7
medical research (7) 7
multiple treatments (7) 7
outcomes (7) 7
prevalence (7) 7
public, environmental & occupational health (7) 7
research (7) 7
risk stratification (7) 7
telephonic communication (7) 7
therapeutic use (7) 7
united kingdom - epidemiology (7) 7
ursodeoxycholic acid (7) 7
acute disease (6) 6
advertising (6) 6
antiviral agents (6) 6
antiviral agents - therapeutic use (6) 6
apoptosis (6) 6
arrangements for measuring two or more variables not coveredin a single other subclass (6) 6
bile (6) 6
cholangitis, sclerosing - diagnosis (6) 6
coaches & managers (6) 6
cryptography (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9773, pp. 1256 - 1263
Summary Background Cytomegalovirus end-organ disease can be prevented by giving ganciclovir when viraemia is detected in allograft recipients. Values of viral... 
Internal Medicine | PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | LIVER-TRANSPLANTATION | VIRUS | LOAD | DISEASE | PREVENTION | PREEMPTIVE THERAPY | RENAL-TRANSPLANTATION | INFECTION | VALGANCICLOVIR | Liver Transplantation | Adjuvants, Immunologic - administration & dosage | Viral Envelope Proteins - pharmacology | Humans | Middle Aged | DNA, Viral - isolation & purification | Male | Organ Transplantation | Cytomegalovirus Vaccines - administration & dosage | Cytomegalovirus Infections - prevention & control | Time Factors | Polymerase Chain Reaction | Polysorbates - administration & dosage | Adult | Female | Immunosuppressive Agents - administration & dosage | Cytomegalovirus - genetics | Cytomegalovirus - isolation & purification | Viremia - diagnosis | Enzyme-Linked Immunosorbent Assay | Squalene - administration & dosage | Treatment Outcome | Kidney Transplantation | Viral Envelope Proteins - administration & dosage | Cytomegalovirus Infections - diagnosis | Antibodies, Viral - isolation & purification | Cytomegalovirus - immunology | Cytomegalovirus Vaccines - pharmacology | Viremia - prevention & control | Immunosuppressive Agents - adverse effects | Aged | Organ transplant recipients | Usage | Viral vaccines | Cytomegaloviruses | Health aspects | Design | Clinical trials | Genomes | Disease | Blood products
Journal Article
Molecular pharmacology, ISSN 1521-0111, 2014, Volume 85, Issue 6, pp. 830 - 838
Journal Article
Journal of hepatology, ISSN 0168-8278, 2019, Volume 71, Issue 2, pp. 371 - 378
[Display omitted] •Established blood tests can be used in primary care to stratify patients with fatty liver disease.•A 2-step pathway (FIB-4 followed by ELF™... 
Cirrhosis | NAFLD | Clinical management | Cost effectiveness | Steatohepatitis | FIB-4 | Non-invasive fibrosis test | ELF | MORTALITY | STAGE | RISK | OBESITY | NONINVASIVE MARKERS | ADVANCED FIBROSIS | GASTROENTEROLOGY & HEPATOLOGY | Liver diseases | Fatty liver | Blood tests | Fibrosis | Primary care | Alcohol use
Journal Article
Gut, ISSN 0017-5749, 09/2018, Volume 67, Issue 9, pp. 1568 - 1594
Primary biliary cholangitis (formerly known as primary biliary cirrhosis, PBC) is an autoimmune liver disease in which a cycle of immune mediated biliary... 
obeticholic acid | guidelines | autoimmune liver disease | care pathway | ursodeoxycholic acid | CLINICAL-PRACTICE GUIDELINES | RANDOMIZED CONTROLLED-TRIALS | URSODEOXYCHOLIC-ACID THERAPY | SIGNIFICANT PORTAL-HYPERTENSION | LIVER STIFFNESS MEASUREMENT | ORAL NALTREXONE TREATMENT | QUALITY-OF-LIFE | PLACEBO-CONTROLLED TRIAL | GASTROENTEROLOGY & HEPATOLOGY | PRIMARY SCLEROSING CHOLANGITIS | GENOME-WIDE ASSOCIATION | Predictive Value of Tests | Risk Assessment | Autoantibodies - blood | Humans | Risk Factors | Treatment Outcome | United Kingdom | Alanine Transaminase - blood | Cholangitis - diagnosis | Mitochondria - immunology | Biomarkers - blood | Cholangitis - blood | Chenodeoxycholic Acid - analogs & derivatives | Cholagogues and Choleretics - therapeutic use | Disease Progression | Ursodeoxycholic Acid - therapeutic use | Bilirubin - blood | Societies, Medical | Sensitivity and Specificity | Chenodeoxycholic Acid - therapeutic use | Gastroenterology | Liver Cirrhosis, Biliary | Cholangitis - therapy | Alkaline Phosphatase - blood | Primary biliary cirrhosis | Alkaline phosphatase | Epithelial cells | Systematic review | Bilirubin | Phosphatase | Ursodeoxycholic acid | Liver cancer | Hepatitis | Hepatology | Atherosclerosis | Hypertension | Immunoglobulins | Liver diseases | Cholangitis | Vitamin deficiency | Management | Patients | Cirrhosis | Cell injury | Biopsy | Fibrosis | Cholestasis | Bile | 2312 | 1506 | Guidelines
Journal Article